These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells. Hennig EE; Conney AH; Wei SJ Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364 [TBL] [Abstract][Full Text] [Related]
44. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG. Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738 [TBL] [Abstract][Full Text] [Related]
45. A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. Watkins S; Madison J; Davis E; Sakamoto Y; Galliano M; Minchiotti L; Putnam FW Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5959-63. PubMed ID: 2068071 [TBL] [Abstract][Full Text] [Related]
46. Molecular cloning and characterization of a mammalian excision repair gene that partially restores UV resistance to xeroderma pigmentosum complementation group D cells. Arrand JE; Bone NM; Johnson RT Proc Natl Acad Sci U S A; 1989 Sep; 86(18):6997-7001. PubMed ID: 2780557 [TBL] [Abstract][Full Text] [Related]
47. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Flejter WL; McDaniel LD; Johns D; Friedberg EC; Schultz RA Proc Natl Acad Sci U S A; 1992 Jan; 89(1):261-5. PubMed ID: 1729695 [TBL] [Abstract][Full Text] [Related]
48. Factor IXMadrid 2: a deletion/insertion in factor IX gene which abolishes the sequence of the donor junction at the exon IV-intron d splice site. Solera J; Magallón M; Martin-Villar J; Coloma A Am J Hum Genet; 1992 Feb; 50(2):434-7. PubMed ID: 1346483 [TBL] [Abstract][Full Text] [Related]
49. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Yuasa M; Masutani C; Eki T; Hanaoka F Oncogene; 2000 Sep; 19(41):4721-8. PubMed ID: 11032022 [TBL] [Abstract][Full Text] [Related]
50. Splicing of the Petunia cytochrome oxidase subunit II intron. Pruitt KD; Hanson MR Curr Genet; 1991 Mar; 19(3):191-7. PubMed ID: 1714357 [TBL] [Abstract][Full Text] [Related]
51. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D. Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650 [TBL] [Abstract][Full Text] [Related]
52. Analysis of a splice acceptor site mutation which produces multiple splicing abnormalities in the human argininosuccinate synthetase locus. Su TS; Lin LH J Biol Chem; 1990 Nov; 265(32):19716-20. PubMed ID: 2246255 [TBL] [Abstract][Full Text] [Related]
53. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex. Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512 [TBL] [Abstract][Full Text] [Related]
54. Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma. Hsu HC; Huang AM; Lai PL; Chien WM; Peng SY; Lin SW Hepatology; 1994 Jan; 19(1):122-8. PubMed ID: 7903951 [TBL] [Abstract][Full Text] [Related]
55. Expression of mitochondrial genes and DNA-repair-related nuclear genes is altered in xeroderma pigmentosum fibroblasts. Xia X; Werner D; Popanda O; Thielmann HW J Cancer Res Clin Oncol; 1994; 120(8):454-64. PubMed ID: 8207043 [TBL] [Abstract][Full Text] [Related]
56. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670 [TBL] [Abstract][Full Text] [Related]
57. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C. Legerski R; Peterson C Nature; 1992 Sep; 359(6390):70-3. PubMed ID: 1522891 [TBL] [Abstract][Full Text] [Related]
58. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Khan SG; Muniz-Medina V; Shahlavi T; Baker CC; Inui H; Ueda T; Emmert S; Schneider TD; Kraemer KH Nucleic Acids Res; 2002 Aug; 30(16):3624-31. PubMed ID: 12177305 [TBL] [Abstract][Full Text] [Related]
59. An XPA gene splicing mutation resulting in trace protein expression in an elderly patient with xeroderma pigmentosum group A without neurological abnormalities. Takahashi Y; Endo Y; Kusaka-Kikushima A; Nakamaura S; Nakazawa Y; Ogi T; Uryu M; Tsuji G; Furue M; Moriwaki S Br J Dermatol; 2017 Jul; 177(1):253-257. PubMed ID: 27603812 [TBL] [Abstract][Full Text] [Related]
60. Infrequent mutation of the ras genes in skin tumors of xeroderma pigmentosum patients in Japan. Ishizaki K; Tsujimura T; Nakai M; Nishigori C; Sato K; Katayama S; Kurimura O; Yoshikawa K; Imamura S; Ikenaga M Int J Cancer; 1992 Feb; 50(3):382-5. PubMed ID: 1735606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]